<bill session="113" type="h" number="4250" updated="2016-10-25T16:11:40Z">
  <state datetime="2014-07-28T17:52:43-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2014-07-28T17:52:43-04:00"/>
  </status>
  <introduced datetime="2014-03-13"/>
  <titles>
    <title type="short" as="introduced">Sunscreen Innovation Act</title>
    <title type="short" as="reported to house">Sunscreen Innovation Act</title>
    <title type="short" as="passed house">Sunscreen Innovation Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes.</title>
    <title type="display">Sunscreen Innovation Act</title>
  </titles>
  <sponsor bioguide_id="W000413"/>
  <cosponsors>
    <cosponsor bioguide_id="B001282" joined="2014-03-27"/>
    <cosponsor bioguide_id="B001252" joined="2014-04-29"/>
    <cosponsor bioguide_id="B001242" joined="2014-05-06"/>
    <cosponsor bioguide_id="B001243" joined="2014-04-10"/>
    <cosponsor bioguide_id="C001083" joined="2014-04-07"/>
    <cosponsor bioguide_id="C000266" joined="2014-07-10"/>
    <cosponsor bioguide_id="C001045" joined="2014-04-29"/>
    <cosponsor bioguide_id="D000604" joined="2014-04-29"/>
    <cosponsor bioguide_id="D000600" joined="2014-06-02"/>
    <cosponsor bioguide_id="D000355" joined="2014-03-13"/>
    <cosponsor bioguide_id="E000291" joined="2014-04-07"/>
    <cosponsor bioguide_id="F000030" joined="2014-03-27"/>
    <cosponsor bioguide_id="F000459" joined="2014-07-08"/>
    <cosponsor bioguide_id="F000445" joined="2014-04-07"/>
    <cosponsor bioguide_id="G000560" joined="2014-05-01"/>
    <cosponsor bioguide_id="G000567" joined="2014-04-10"/>
    <cosponsor bioguide_id="G000558" joined="2014-03-27"/>
    <cosponsor bioguide_id="J000292" joined="2014-06-02"/>
    <cosponsor bioguide_id="K000220" joined="2014-04-29"/>
    <cosponsor bioguide_id="L000567" joined="2014-04-07"/>
    <cosponsor bioguide_id="L000575" joined="2014-04-29"/>
    <cosponsor bioguide_id="L000566" joined="2014-04-30"/>
    <cosponsor bioguide_id="M000087" joined="2014-04-10"/>
    <cosponsor bioguide_id="M001142" joined="2014-06-02"/>
    <cosponsor bioguide_id="M001151" joined="2014-05-22"/>
    <cosponsor bioguide_id="N000184" joined="2014-04-29"/>
    <cosponsor bioguide_id="P000593" joined="2014-05-09"/>
    <cosponsor bioguide_id="R000586" joined="2014-07-15"/>
    <cosponsor bioguide_id="R000395" joined="2014-03-27"/>
    <cosponsor bioguide_id="R000583" joined="2014-04-29"/>
    <cosponsor bioguide_id="R000580" joined="2014-06-17"/>
    <cosponsor bioguide_id="R000593" joined="2014-05-06"/>
    <cosponsor bioguide_id="S001187" joined="2014-03-27"/>
    <cosponsor bioguide_id="T000462" joined="2014-03-27"/>
  </cosponsors>
  <actions>
    <action datetime="2014-03-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2014-03-13" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2014-03-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2014-06-19">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2014-06-19">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent .</text>
    </action>
    <action datetime="2014-07-14">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2014-07-15">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2014-07-15" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2014-07-24">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-558.</text>
    </action>
    <calendar datetime="2014-07-24" calendar="Union" number="418">
      <text>Placed on the Union Calendar, Calendar No. 418.</text>
    </calendar>
    <action datetime="2014-07-28T17:39:34-04:00">
      <text>Mr. Whitfield moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2014-07-28T17:39:53-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H6928-6933" label="consideration"/>
    </action>
    <action datetime="2014-07-28T17:39:56-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4250.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2014-07-28T17:52:43-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H6928-6930" label="text"/>
    </vote>
    <action datetime="2014-07-28T17:52:45-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2014-07-29">
      <text>Received in the Senate.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="113" relation="identical" number="2141"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health promotion and preventive care"/>
    <term name="Musculoskeletal and skin diseases"/>
  </subjects>
  <amendments/>
  <summary date="2014-07-28T14:17:38Z" status="Passed House amended">(This measure has not been amended since it was reported to the House on July 24, 2014. The summary of that version is repeated here.)

Sunscreen Innovation Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to establish a process for the review and approval of over-the-counter (OTC) sunscreen active ingredients.

Allows any person to request that the Secretary of Health and Human Services (HHS) determine whether an OTC sunscreen active ingredient or combination of ingredients is safe and effective.

Requires the Secretary to review any request regarding a sunscreen active ingredient or combination of ingredients that has been in use and that is not included in the stayed sunscreen monograph published by the Food and Drug Administration (FDA).

Directs the Secretary to invite the sponsor of the request to provide data and other information on the safety and efficacy of the sunscreen active ingredient or combination of ingredients. Requires the Secretary to determine whether the provided information is sufficient to conduct a review, and if so, file the request, and if not, explain to the sponsor why the provided information is insufficient.

Requires the Director of the Center for Drug Evaluation and Research to complete a review of a filed request and determine the safety and efficacy of the sunscreen active ingredient or combination of ingredients within 300 days for new requests or a shorter timeframe for requests pending before enactment of this Act. Directs the Commissioner of Food and Drugs to make the determination if the Director does not make a determination in the allowed timeframe.

Allows sunscreen active ingredients that are determined to be safe and effective to be used in OTC sunscreen products.

Directs the Comptroller General (GAO) to report on the progress of the Secretary in establishing this process and the role of the Commissioner of Food and Drugs in issuing determinations on pending requests. Requires the Secretary to report on the decisions made about the safety and efficacy of sunscreen active ingredients, the amount of time between submission and decision for each request, the cost of the review process, and recommended improvements to the review process.</summary>
  <committee-reports>
    <report>H. Rept. 113-558</report>
  </committee-reports>
</bill>
